BMS1P15

Across TCGA pan-cancer cohorts, BMS1P15 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated BMS1P15 data layer compared with 1 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher BMS1P15 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated BMS1P15 expression acts as an unfavorable survival marker, although some lineages such as UCS and SKCM show a favorable association.

UCEC, UCS, and MESO are the cancer types where BMS1P15 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	All	0.514	0.694	<.001	98	view →
UCS	OS	Tertile	All	0.695	0.282	.002	90	view →
MESO	OS	Tertile	IV	0.218	0.703	.002	54	view →
LIHC	OS	Tertile	All	0.564	0.732	<.001	45	view →
LUSC	DFS	Tertile	III,IV	0.173	0.551	.003	38	view →
SKCM	OS	Median	III,IV	0.777	0.629	.006	26	view →
THYM	OS	Tertile	All	0.875	1.000	.012	22	view →
READ	OS	Tertile	III,IV	0.955	0.447	.014	16	view →
GBM	OS	Tertile	All	0.532	0.265	.011	13	view →
BRCA	DFS	Median	II,III,IV	0.663	0.471	.012	12	view →
ACC	DFS	Tertile	III,IV	0.263	0.688	.015	10	view →
KICH	DFS	Tertile	III,IV	0.043	0.897	.045	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

BMS1P15–UCEC (DFS)

Open the UCEC breakdown →